Medication info
Weltra Tablets

Weltra Tablets

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›37.5mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
Aprogen Pharmaceuticals Co., Ltd.
Appearance
Pale yellow oblong film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200805631 · Notified 2008.05.20 · Insurance code 645203440

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses, and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible period. Do not use this drug for longer than necessary. If long-term use is required due to the nature and severity of the disease, conduct regular monitoring to determine whether continued use of this drug is appropriate. Elderly Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to elderly patients aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and hemofiltration, this drug does not need to be readministered after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses, and do not exceed 8 tablets per day.

Ingredients

Manufacturer
Aprogen Pharmaceuticals Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • moderate to severe chronic pain
View approved original text

This medication is used to relieve acute and chronic pain that ranges from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses, and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible period. Do not use this drug for longer than necessary. If long-term use is required due to the nature and severity of the disease, conduct regular monitoring to determine whether continued use of this drug is appropriate. Elderly Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to elderly patients aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and hemofiltration, this drug does not need to be readministered after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses, and do not exceed 8 tablets per day.

Precautions

This medication may put a burden on the liver, so individuals who regularly consume more than three glasses of alcohol daily must consult a doctor or pharmacist before taking this drug. While taking this medication, serious skin reactions such as rashes or blisters may occur; if such symptoms appear, immediately discontinue use and inform medical personnel. One of the active ingredients in this drug, tramadol, can induce seizures, so patients with a history of seizures or those at high risk of seizures should use this medication with caution, and the risk of seizures may increase when taken with certain antidepressants or narcotic analgesics. Rarely, severe allergic reactions may occur after taking this drug, so if symptoms such as difficulty breathing or hives develop, seek medical assistance immediately. This medication may impair breathing in acute asthma patients, so it should only be used in environments where medical equipment is prepared. Taking this drug in conjunction with alcohol or central nervous system depressants may lead to severe drowsiness, respiratory depression, or coma; thus, great caution is advised when combining these substances. Patients with head injuries or elevated intracranial pressure should use this medication cautiously, as it may worsen symptoms due to respiratory depression and increased brain pressure. This drug can lead to physical and psychological dependence, so careful monitoring of dependence is essential during long-term use. Due to the inclusion of acetaminophen, patients with impaired liver function should consult a doctor before taking this medication and avoid concomitant use of other acetaminophen products. Particularly, individuals who metabolize this drug rapidly due to genetic factors may be at higher risk for respiratory depression and should be cautious, and this drug should not be administered to pediatric patients. Patients with sleep apnea or hypoxia should continually monitor symptom changes as symptoms may worsen after taking this drug. This medication can lead to hyponatremia, so elderly patients or those at risk for hyponatremia should regularly check their blood sodium levels. Ensure not to exceed the recommended dosage while taking this medication and be cautious not to use it alongside other medications with similar ingredients. Abrupt discontinuation may result in withdrawal symptoms such as anxiety, insomnia, and sweating, so it is safe to taper off gradually under the direction of a physician. Drowsiness or dizziness may occur when driving or operating machinery, so caution is necessary if these symptoms are present. In case of overdose, severe side effects such as respiratory depression, seizures, and liver damage may occur; seek medical attention immediately if suspected.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, death, decreased appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, neuroexcitability, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, spatial disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory impairment, tremor, sensory abnormality, attention disorder, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, elevated liver enzymes, generalized pruritus, sweating, urinary disorders, erectile dysfunction, weakness, chest pain, abnormal emotions, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylactic reactions, influence on emotional instability, delirium, suicidal ideation, muscle rigidity syndrome, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hyponatremia, fixed rash, weakness, fever, edema, rigidity, syncope, congestive heart failure, stupor, exacerbation of migraine, involuntary muscle contractions, respiratory distress, cough, bronchitis, urinary retention, increased urination, impaired renal function parameters, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of stomach cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, decreased appetite, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, increased white blood cells, increased white blood count, palpitations, arrhythmias, exacerbation of hypertension, aortic stenosis, bleeding, increased cholesterol levels, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, liver dysfunction, nausea, vertigo, stupor, dyspnea, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, dyspepsia, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory tract syndrome, lip swelling, agitation, neuroexcitability, hyperactivity, panic attacks, severe anxiety, tinnitus, abnormal central nervous system response, urticaria, bronchospasm, toxic skin necrosis, opioid-induced hyperalgesia, withdrawal symptoms, acute or chronic adrenal insufficiency symptoms, QT prolongation, abdominal discomfort, lethargy, pallor, hyperhidrosis, renal tubular necrosis, coagulopathy

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container that does not allow air to enter, ideally at a temperature between 1 and 30 degrees Celsius. This way, the efficacy of the drug can be maintained for an extended period.

Appearance and packaging

Appearance

Pale yellow oblong film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.